Mechanisms of disease: Selective inhibition of 11beta-hydroxysteroid dehydrogenase type 1 as a novel treatment for the metabolic syndrome. (Nature clinical practice. Endocrinology and metabolism, 2005)

(untitled) - Tomlinson, J; Stewart, P